Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Update on the Role of Rifaximin in Digestive Diseases.
Dumitrascu DL, Bakulin I, Berzigotti A, Cravo M, Gombošová L, Lukas M, Pietrzak A, Remes-Troche JM, Romero-Gómez M, Balmori MA, Gonçalves TC, Hamzaoui L, Juricek R, Moreira L, Neubauer K, Surdea-Blaga T, Tikhonov IN, Trna J, Ianiro G, Ponziani FR, Gasbarrini A. Dumitrascu DL, et al. Among authors: berzigotti a. J Gastrointestin Liver Dis. 2023 Apr 1;32(1):92-109. doi: 10.15403/jgld-4871. J Gastrointestin Liver Dis. 2023. PMID: 37004222 Free article. Review.
Physical activity and liver diseases.
Berzigotti A, Saran U, Dufour JF. Berzigotti A, et al. Hepatology. 2016 Mar;63(3):1026-40. doi: 10.1002/hep.28132. Epub 2015 Dec 18. Hepatology. 2016. PMID: 26313307 Review.
Pharmacologic management of portal hypertension.
Berzigotti A, Bosch J. Berzigotti A, et al. Clin Liver Dis. 2014 May;18(2):303-17. doi: 10.1016/j.cld.2013.12.003. Epub 2014 Feb 25. Clin Liver Dis. 2014. PMID: 24679496 Review.
Emerging therapies for portal hypertension in cirrhosis.
Nair H, Berzigotti A, Bosch J. Nair H, et al. Among authors: berzigotti a. Expert Opin Emerg Drugs. 2016 Jun;21(2):167-81. doi: 10.1080/14728214.2016.1184647. Epub 2016 May 23. Expert Opin Emerg Drugs. 2016. PMID: 27148904 Review.
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
Simón-Talero M, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-Martinez R, Dam A, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Bañares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-Gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genescà J; Baveno VI-SPSS group from the Baveno Cooperation. Simón-Talero M, et al. Among authors: berzigotti a. Gastroenterology. 2018 May;154(6):1694-1705.e4. doi: 10.1053/j.gastro.2018.01.028. Epub 2018 Jan 31. Gastroenterology. 2018. PMID: 29360462 Free article.
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S, Sebastiani G, Viganò M, Ampuero J, Wai-Sun Wong V, Boursier J, Berzigotti A, Bugianesi E, Fracanzani AL, Cammà C, Enea M, Grottes MD, Di Marco V, Younes R, Keyrouz A, Mazzola S, Mendoza Y, Pennisi G, Romero-Gomez M, Craxì A, de Ledinghen V. Petta S, et al. Among authors: berzigotti a. Clin Gastroenterol Hepatol. 2021 Apr;19(4):806-815.e5. doi: 10.1016/j.cgh.2020.06.045. Epub 2020 Jul 2. Clin Gastroenterol Hepatol. 2021. PMID: 32621970 Free article.
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.
Pennisi G, Enea M, Romero-Gomez M, Viganò M, Bugianesi E, Wong VW, Fracanzani AL, Sebastiani G, Boursier J, Berzigotti A, Eslam M, Ampuero J, Benmassaoud A, La Mantia C, Mendoza YP, George J, Craxì A, Camma' C, de Ledinghen V, Petta S. Pennisi G, et al. Among authors: berzigotti a. Aliment Pharmacol Ther. 2022 Mar;55(5):604-615. doi: 10.1111/apt.16763. Epub 2022 Jan 5. Aliment Pharmacol Ther. 2022. PMID: 34988994 Free article.
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease.
Pennisi G, Pipitone RM, Cabibi D, Enea M, Romero-Gomez M, Viganò M, Bugianesi E, Wong VW, Fracanzani AL, Sebastiani G, Berzigotti A, Di Salvo F, Giannone AG, La Mantia C, Lupo G, Porcasi R, Vernuccio F, Zito R, Di Marco V, Cammà C, Craxì A, de Ledinghen V, Grimaudo S, Petta S. Pennisi G, et al. Among authors: berzigotti a. Liver Int. 2022 May;42(5):1037-1048. doi: 10.1111/liv.15232. Epub 2022 Mar 12. Liver Int. 2022. PMID: 35246921 Free article.
279 results